Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
August 13, 2012

Quintiles Snaps Up EA

  • Quintiles said it acquired Expression Analysis (EA), a provider of genomics testing and analysis, for an undisclosed price with greater personalized medicine development in mind.

    The deal combines Quintiles’ network of more than 25,000 professionals in 60 countries—as well as its clinical, commercial, consulting and capital biopharmaceutical services—with EA’s offerings, which include whole genome to focused-set gene expression profiling and genotyping assays; DNA and RNA sequencing services; sequence enrichment technologies; and bioinformatics support.

    “The addition of EA's Genomic Know-How® to Quintiles is another step forward in our efforts to bring personalized medicine into mainstream drug development," Thomas Wollman, svp, Quintiles Global Laboratories, said in a statement.

    Said Steve McPhail, EA President and CEO, in the same statement: “Our mission perfectly fits Quintiles’ strategy to use genomic data and advanced informatics to yield actionable insights and more effective personalized treatments.”

    Quintiles Global Laboratories supports trials worldwide with wholly owned facilities in the U.S., Europe, South Africa, India, China, Singapore, and Japan, and a network of affiliate labs in Argentina and Brazil.

Related content

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.